Voice Changes During ECT

Overview

Depressed patients talk differently when they are depressed compared to when they are well. But it is hard to actually measure what the differences are. The study team will record voice samples from patients with mood disturbances, like depression, over the course of their receiving an electroconvulsive therapy (ECT) series. The study team will try and measure or quantify exactly what has changed in their speech and voice. The study team will choose ECT as it is one of the most effective and rapid treatment for depression. The study team will use a service provided by a company, NeuroLex, who has complex computer programs (artificial intelligence, AI) to analyze the voice samples.

Full Title of Study: “Voice Analysis in Patients Receiving Electroconvulsive Therapy”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: February 17, 2021

Interventions

  • Other: Questionnaire
    • 3 voice recording tasks and 1 text entry task will be performed.

Arms, Groups and Cohorts

  • ECT and Voice Recorded Group
    • This is an add-on study of voice samples to be gathered during ECT clinical treatments. The ONLY research procedures are four tasks on an online form, one text task and three voice recording tasks. These voice recordings will take place in a private room on the 5th floor of the Institute of Psychiatry on the same day of a patient’s ECT treatment. The questionnaire will take less than 10 minutes.

Clinical Trial Outcome Measures

Primary Measures

  • Acoustic feature: zero crossing rate
    • Time Frame: Throughout a course of electroconvulsive therapy (ECT) which may last between 2 and 7 weeks.
    • crossings per second
  • Acoustic feature: energy and entropy
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • decibels
  • Acoustic feature: spectral centroid, spectral spread, spectral entropy, spectral flux, spectral rolloff
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • hertz
  • Acoustic feature: Mel-Frequency Cepstral Coefficients, Chroma Vectors, and Chroma Deviation
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • unitless
  • Linguistic features: question ratio, filler ratio, number ratio, type token ratio
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • unitless ratio
  • Linguistic features: verb frequency, noun frequency, pronoun frequency, adverb frequency, adjective frequency, particle frequency, conjunction frequency, pronoun frequency
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • percentage
  • Linguistic features: standardized word entropy
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • decibels/log(total word count)
  • Linguistic features: Brunets index
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • W (lexical richness)
  • Linguistic features: Honores statistic
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • R (lexical richness)
  • Linguistic features: rate of speech
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • words per minute
  • Meta-features: fatigue
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Machine learning approach to evaluate binary outcome: fatigued or awake
  • Meta-features: audio quality
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Machine learning approach to evaluate binary outcome: bad or good
  • Meta-features: sentiment
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Machine learning approach to evaluate binary outcome: sad or happy
  • Meta-features: stress
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Machine learning approach to evaluate binary outcome: stressed or not stressed
  • Meta-features: gender
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Machine learning approach to evaluate binary outcome: male or female
  • Meta-features: accent
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Machine learning approach to evaluate a categorical outcome of accent region: england, indian, australian, etc.
  • Meta-features: length
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • seconds
  • Meta-features: age
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Machine learning approach to evaluate estimated decade-age: 10s, 20s, 30s, 40s, 50s, 60s, 70s, 80s, 90s, etc.
  • Comparing the voice feature(s) with greatest statistically significant change to Patient Health Questionnaire (PHQ)-9 scores
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • The voice feature(s) found to have changed most significantly will be compared to Patient Health Questionnaire-9 scores which approach a total score that is less than 8, indicative of reduced depressive symptoms throughout Electroconvulsive Therapy
  • Acoustic Feature Specific Changes within and across sessions
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Generalized mixed linear model will be used to evaluate which acoustic features change with P value threshold of <0.05
  • Linguistic Feature Specific Changes within and across sessions
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Generalized mixed linear model will be used to evaluate which linguistic features change with P value threshold of <0.05
  • Meta-Feature Specific Changes within and across sessions
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Generalized mixed linear model will be used to evaluate which meta features change with P value threshold of <0.05

Secondary Measures

  • Acoustic Feature Specific Changes between sessions
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Acoustic voice features will be evaluated using continuous averages using one sample t-tests and we will be testing the difference over time to a null hypothesis of 0 (for no change) in the one sample t-test.
  • Linguistic Feature Specific Changes between sessions
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Linguistic voice features will be evaluated using continuous averages using one sample t-tests and we will be testing the difference over time to a null hypothesis of 0 (for no change) in the one sample t-test.
  • Meta-Feature Specific Changes between sessions
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Meta-voice features will be evaluated using continuous averages using one sample t-tests and we will be testing the difference over time to a null hypothesis of 0 (for no change) in the one sample t-test.
  • Patient Chart Review Data: Age
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • years
  • Patient Chart Review Data: inpatient/outpatient status
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • binary: inpatient or outpatient
  • Patient Chart Review Data: gender
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • male, female, unspecified
  • Patient Chart Review Data: race
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • african american, caucasian, hispanic, asian american, etc.
  • Patient Chart Review Data: Psychiatric diagnosis for ECT
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Diagnosis indicated for receiving ECT
  • Patient Chart Review Data: PHQ-9 score at each session
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Total (0-27) on 9 question scale
  • Patient Chart Review Data: Psychiatric hospitalizations
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Number
  • Patient Chart Review Data: Past Psychiatric Medication Trials
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Number
  • Patient Chart Review Data: Current Psychiatric Medication Trials
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Number
  • Patient Chart Review Data: Classes of Current Psychiatric Medications
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Categorical: Sedative, Selective Serotonin Reuptake Inhibitor, etc.
  • Patient Chart Review Data: Suicidal Ideation at ECT consult
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Binary: yes/no
  • Patient Chart Review Data: Past Suicide Attempts
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Number
  • Patient Chart Review Data: Psychiatric Review of Systems
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Descriptive, categorical
  • Patient Chart Review Data: Family Psychiatric History
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Categorical regarding psychiatric diagnoses of family members
  • Patient Chart Review Data: Number of non-psychiatric medical diagnoses
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Number
  • Patient Chart Review Data: Past non-psychiatric medication trials
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Number
  • Patient Chart Review Data: Current non-psychiatric Medications
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Number
  • Patient Chart Review Data: Tobacco use history
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Binary (yes/no)
  • Patient Chart Review Data: Tobacco use pack year
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • pack-year (total years smoked*average packs per day)
  • Patient Chart Review Data: Prior ECT treatment
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Binary (yes/no)
  • Patient Chart Review Data: total # of prior ECT treatments for response in the past
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Numerical
  • Patient Chart Review Data: Prior transcranial magnetic stimulation (TMS) treatment
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Binary (yes/no)
  • Patient Chart Review Data: Prior response to ECT or TMS
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Categorical
  • Patient Chart Review Data against voice features
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • We will evaluate voice features with statistically significant changes against respective participant chart review data using a general linear model with a clustering component for repeated measures which may also be applied to contrast statements evaluating overall change over time (from baseline to end).
  • Generating ROC curves: stress
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Clinically determined stress level (mood) will be compared to meta-feature extractions of stressed vs. not stressed from voice recordings will be used to calculate an area under the receiver operating curve (AUOC)
  • Generating ROC curves: fatigue
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Clinically determined fatigue (motor) will be compared to meta-feature extractions of fatigued vs. awake from voice recordings will be used to calculate an area under the receiver operating curve (AUOC)
  • Generating ROC curves: sentiment
    • Time Frame: Throughout a course of electroconvulsive therapy which may last between 2 and 7 weeks.
    • Clinically determined sentiment (affect and mood) will be compared to meta-feature extractions of happy vs. sad from voice recordings will be used to calculate an area under the receiver operating curve (AUOC)

Participating in This Clinical Trial

Inclusion Criteria

  • Any candidate for electroconvulsive therapy who is about to initiate their ECT course at Medical University of South Carolina (MUSC) for a clinically indicated diagnosis – Age 18 to 90 years old – Able to speak and understand English – Able to give consent to participate in the study EXCLUSION CRITERIA:

  • Any medical condition that limits the ability to speak or speak clearly, for example a history of head and/or neck cancer, spinal cord injury affecting speech, amyotrophic lateral sclerosis, or those with absence of critical anatomical structures involved in speech. – Any voice characteristics that may limit the ability to speak English clearly including speech impediments or heavy accents (as evidenced by the pronunciation of the English language in such a non-standard way that research staff). If study staff have significant difficulty understanding the participant's responses in conversation, this may warrant exclusion. – Patients who are receiving ECT by involuntary order, by order of their guardian, or by a court order, as evidenced by patient report or brief chart review. – Patients who elect to not receive their full course of ECT at MUSC.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 89 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Medical University of South Carolina
  • Provider of Information About this Clinical Study
    • Principal Investigator: Sean Christensen, Resident Physician – Medical University of South Carolina
  • Overall Official(s)
    • Sean Christensen, MD, Principal Investigator, Medical University of South Carolina

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.